Chabiotech Co.,Ltd. (KOSDAQ:085660)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,880
+140 (1.19%)
Jun 12, 2026, 3:30 PM KST

Chabiotech Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
1,293,8191,268,2541,045,049953,951844,583727,476
Other Revenue
-0-0-0-0-0-
1,293,8191,268,2541,045,049953,951844,583727,476
Revenue Growth (YoY)
15.85%21.36%9.55%12.95%16.10%9.44%
Cost of Revenue
936,276914,057775,225682,936643,558513,978
Gross Profit
357,543354,197269,824271,016201,025213,498
Selling, General & Admin
341,402321,715270,689234,513208,490172,436
Research & Development
25,59924,58515,98314,61414,35913,050
Amortization of Goodwill & Intangibles
1,6381,6792,7852,3282,6151,869
Other Operating Expenses
15,64515,93313,37211,17010,5289,563
Operating Expenses
432,666411,343329,799280,441254,693207,101
Operating Income
-75,123-57,147-59,975-9,425-53,6696,397
Interest Expense
-54,908-54,847-37,165-29,101-20,868-14,534
Interest & Investment Income
11,47011,46210,44212,9236,5935,177
Earnings From Equity Investments
12,016-332.8717,604-281.48-13,489-246.17
Currency Exchange Gain (Loss)
13,323-6,08717,8051,5295,4426,934
Other Non Operating Income (Expenses)
-33,346-15,75128,75123,76111,713-14,485
EBT Excluding Unusual Items
-126,567-122,702-22,538-594.36-64,278-10,756
Gain (Loss) on Sale of Investments
69.16542.91263.583,870-6,9881,424
Gain (Loss) on Sale of Assets
55,34129,36121,904-26.53138.34-657.11
Asset Writedown
-41,043-41,043-1,132-453.62-329101.17
Other Unusual Items
-7,021-9,421-1,411391.99154.47-144.56
Pretax Income
-119,221-143,263-2,9143,188-71,302-10,033
Income Tax Expense
3,1283,4468,3468,748-1,64311,811
Earnings From Continuing Operations
-122,349-146,708-11,260-5,560-69,659-21,844
Net Income to Company
-122,349-146,708-11,260-5,560-69,659-21,844
Minority Interest in Earnings
48,89636,8326,496-2,87122,1167,875
Net Income
-73,453-109,876-4,764-8,431-47,543-13,968
Net Income to Common
-73,453-109,876-4,764-8,431-47,543-13,968
Shares Outstanding (Basic)
756732565655
Shares Outstanding (Diluted)
756732575655
Shares Change (YoY)
137.28%111.36%-44.35%1.43%3.24%3.82%
EPS (Basic)
-975.13-1636.98-150.00-149.80-844.95-256.29
EPS (Diluted)
-976.81-1649.00-150.00-149.80-845.00-256.29
Free Cash Flow
-284,552-219,089-142,191-57,346-139,754-86,350
Free Cash Flow Per Share
-3777.60-3264.08-4477.42-1004.83-2483.78-1584.36
Gross Margin
27.63%27.93%25.82%28.41%23.80%29.35%
Operating Margin
-5.81%-4.51%-5.74%-0.99%-6.35%0.88%
Profit Margin
-5.68%-8.66%-0.46%-0.88%-5.63%-1.92%
Free Cash Flow Margin
-21.99%-17.27%-13.61%-6.01%-16.55%-11.87%
EBITDA
-17,990-853.71-14,96628,374-21,14934,260
EBITDA Margin
-1.39%-0.07%-1.43%2.97%-2.50%4.71%
D&A For EBITDA
57,13356,29345,00937,79932,52027,862
EBIT
-75,123-57,147-59,975-9,425-53,6696,397
EBIT Margin
-5.81%-4.51%-5.74%-0.99%-6.35%0.88%
Effective Tax Rate
---274.41%--
Advertising Expenses
-6,85911,9019,9429,0478,780